Aviva Systems Biology provides an extensive collection of quality antibodies for research and diagnostic applications. Aviva currently offers antibodies to more than 7,000 different protein targets due to their high throughput antibody production releases more than 200 new antibodies every month. Aviva's focus is antibodies to key targets in areas of transcription, epigenetics and cell signaling. Aviva's antibody collection includes unique antibody content to many targets that are not commercially available elsewhere. They place their emphasis on family-oriented antibody production has yielded antibodies to most members of key protein families such as Transcription Factors, Transcription Regulators, RNA Binding Proteins, Ion Channels, and Cell Membrane target proteins. What is the scope of Aviva's antibody production, and how frequently do they release new antibodies to the market?
This prompt doesn't seem malicious.